Overview of Advil Cold & Sinus
Quick Facts
| Property | Description |
|---|---|
| Active Ingredients | Ibuprofen, Pseudoephedrine HCl |
| Form | Oral dosage form (Caplet, Tablet, Liquid-filled capsule) |
| Pharmacological Class | Analgesic and Nasal Decongestant Combination |
| Common Use | Symptomatic relief of discomfort associated with cold and sinus issues |
| Origin | Synthetic organic compounds |
What Type of Medicine is Advil Cold & Sinus?
Advil Cold & Sinus is defined as a synthetic fixed-dose combination product intended for oral administration, meaning it integrates two distinct active pharmaceutical ingredients into a single dosage unit. The medicine is officially classified as an analgesic and nasal decongestant combination. This dual-entity nature, which combines an antipyretic pain reliever with a vasoconstrictor, distinguishes it from single-agent preparations. Its development as a combination product is designed to address multiple symptoms simultaneously. The product is typically presented in a non-drowsy formulation for use during the day.
Active Ingredients and Composition
The active composition consists of Ibuprofen and Pseudoephedrine hydrochloride. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derived from propionic acid, utilized for its effects as an analgesic and antipyretic. Pseudoephedrine is a sympathomimetic amine that belongs to the class of nasal decongestants. The unique feature of some Advil Cold & Sinus formulations involves solubilized ibuprofen, a delivery technology designed for potentially faster absorption. This characteristic relates to the specific form and delivery method employed by the manufacturer.
General Purpose: Symptomatic Relief of Congestion and Pain
The medicine's purpose is to achieve combined symptomatic relief by addressing both systemic discomforts and localized congestion, offering temporary relief of typical cold symptoms such as fever and nasal stuffiness. The Ibuprofen component reduces the production of chemical mediators in the body that initiate pain and fever. Concurrently, the Pseudoephedrine component acts as a vasoconstrictor, causing the narrowing of blood vessels in the nasal passages; this action reduces swelling and the fluid accumulation responsible for congestion. This results in a comprehensive effect that targets both general aches and tissue-based fullness, an approach for addressing patient comfort during respiratory ailments.
Regulatory References

